Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands
- Renaud J.S.D. Heine*
- , Ron H.J. Mathijssen
- , Floor A.J. Verbeek
- , Chantal Van Gils
- , Carin A. Uyl-de Groot
*Corresponding author for this work
- IQVIA Rotterdam
Research output: Contribution to journal › Article › Academic › peer-review
2
Citations
(Scopus)
72
Downloads
(Pure)